Top Cannabis Real Estate Stocks for July 2025: REITs with Strong Upside Cannabis REITs are gaining momentum this week as investors seek dividend-paying stocks with long-term growth potential. These companies lease properties to licensed cannabis operators, generating steady income for their shareholders. As the cannabis sector matures, real estate investment trusts provide stability and consistent payouts. The U.S. cannabis market is projected to reach over $45 billion by the end of 2025. Annual growth rate ...

Where Is Cannabis Legal In Europe? https://t.co/QjbJJG0ffC https://t.co/QjbJJG0ffC ...

Where Is Cannabis Legal In Europe?https://t.co/v7YdoXLYSZ https://t.co/sQPKIzHfA7 ...

Could These Marijuana Stocks See A Breakout Soon?Marijuana stock investors are functioning off the success of the cannabis industry. What this means is that no market action represents this progress, so when it occurs it gives hope. At this time cannabis stocks are trading as they used to. But the continuous growth of the cannabis industry provides more optimism about the future. This has now become a big investor topic when speaking on strategy.There have not been enough volatile rises sustained sufficient ...

Bad Bet: Cannabis may be legal in Las Vegas, but because it's illegal at the federal level, casinos can't take the risk of permitting it. https://t.co/jnSrYDRCyj https://t.co/jnSrYDRCyj ...

Core Viewpoint - Canopy Growth has significantly underperformed in the cannabis industry, losing 99% of its value over the past five years, with shares trading under $2, making it unattractive for investment [1][11]. Financial Performance - Canopy Growth reported a net revenue of 65 million Canadian dollars for Q4 of fiscal year 2025, down 11% year-over-year, despite a 4% increase in cannabis revenue in Canada [6]. - The company remains deeply unprofitable, with a net loss per share of CA$1.43, worsening from a CA$1.03 loss per share in the previous year [7]. Market Challenges - The cannabis market is heavily regulated, leading to stiff competition and oversupply issues, particularly in Canada and the U.S., where cannabis remains illegal at the federal level [4][10]. - Canopy Growth's international operations, including its subsidiary Storz & Bickel, have not mitigated the negative impact on overall performance [2][6]. Management Outlook - Management has attempted to present a positive outlook by highlighting a 49% reduction in total debt during fiscal year 2025 and aims to achieve positive adjusted EBITDA in the "near term" [8][9]. - Despite potential long-term opportunities in the U.S. cannabis market, the vague nature of management's goals raises skepticism about the company's future profitability [8][9]. Investment Sentiment - The current lack of revenue growth and the uncertain regulatory environment in the U.S. contribute to the view that Canopy Growth is not an attractive investment option [10][11].

Core Insights - GrowGeneration Corp. has entered into a distribution agreement with V1 Solutions to expand its market presence in the European Union and Costa Rica, targeting the growing demand for hydroponic and organic gardening products [1][2][4] Group 1: EU Expansion - The partnership with V1 Solutions will leverage their strategic relationships with commercial cultivators in Europe, allowing GrowGen to meet the increasing demand for advanced cultivation products as cannabis regulations evolve [2][4] - Target markets in the EU include Germany, Portugal, Malta, Luxembourg, the Netherlands, Czech Republic, Greece, and Macedonia, all of which are experiencing significant cannabis cultivation developments [7] Group 2: Central America Expansion - GrowGen has launched its proprietary brands in Costa Rica, which has issued over 50 licenses for hemp and cannabis production in the past year, positioning it as a key growth market in Central America [3][4] - The favorable growing conditions and developing export infrastructure in Costa Rica enhance its potential for cannabis cultivation [3] Group 3: Product Offerings - GrowGen will supply its proprietary brands, including Drip Hydro, Char Coir, Ion Lighting, Power Si, and The Harvest Company, to commercial cultivators, garden centers, and licensed operators in the targeted regions [2][4] Group 4: International Strategy - The company is exploring additional markets in Eastern Europe and Latin America, aiming to serve high-growth regions through local partnerships and product education [4] - GrowGeneration's international sales infrastructure and regulatory expertise position it well to capitalize on the cannabis cultivation boom in regions with advancing legalization [4]

Group 1: Company Overview - Tilray Brands went public in 2018 and has since faced significant challenges, with the stock losing nearly all its value despite the U.S. cannabis market exceeding $38 billion last year [1][2] - The company has evolved into a global cannabis business, initially focusing on medical cannabis and later expanding into recreational cannabis, hemp foods, and beverages [4][5] - Tilray currently sells over 40 brands of cannabis products and generated $829 million in sales last year, with projected revenue growth to $893 million this year and $943 million next year [5][6] Group 2: Financial Performance - While sales are not a concern, Tilray has struggled with profitability, reporting a free cash flow of minus $92 million and net losses nearing $250 million last year [7][8] - The U.S. cannabis market is expected to grow over 11% annually through 2030, presenting opportunities for Tilray's diverse product portfolio [6] Group 3: Challenges and Risks - The company has faced operational challenges due to varying legal statuses of cannabis across states in the U.S., leading to pricing pressures and competition from the black market [8] - Tilray's rapid expansion has resulted in a 348% increase in diluted share count since 2018, which negatively impacts revenue and profit distribution among shareholders [9][10] - Despite potential future growth, the stock is unlikely to yield significant returns for investors due to ongoing losses and share dilution [11]